Zobrazeno 1 - 10
of 35
pro vyhledávání: '"D. V. Jensen"'
Autor:
Henrik Røgind, Zoreh Rastiemadabadi, Daniel Glinatsi, D. V. Jensen, Annette Hansen, Niels Steen Krogh, Lykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, Natalia Manilo, Jakob M Møller, Mikael Boesen, Lene Terslev, Merete Lund Hetland, Lone Morsel‐Carlsen, Jesper Nørregaard, Mikkel Østergaard, Joshua F. Baker, Simon Krabbe, Søren Jacobsen, Tuan K. Huynh
Publikováno v:
International Journal of Rheumatic Diseases. 23:488-498
OBJECTIVE To investigate whether magnetic resonance imaging (MRI) pathologies in the wrist/hand of rheumatoid arthritis (RA) patients are associated with patient-reported outcomes (PROs) at clinical remission and relapse. METHODS Wrist/hand MRIs and
Autor:
B. Glintborg, D. V. Jensen, L. Terslev, O. Hendricks, M. Østergaard, S. H. Rasmussen, M. Pfeiffer-Jensen, T. Adelsten, A. Colic, K. Danebod, M. Kildemand, A. G. Loft, H. L. Munk, J. K. Pedersen, R. Østgård, C. M. Sørensen, N. Steen Krogh, J. Nørgaard Agerbo, C. Ziegler, M. L. Hetland
Publikováno v:
Annals of the Rheumatic Diseases. 81:440.2-441
BackgroundDigital solutions for online monitoring of chronic diseases are increasingly implemented in health care, but not all patients might have access, skills, or interest in using them. Fueled by the COVID-19 pandemic and the urgent need for remo
Autor:
B. Glintborg, D. V. Jensen, L. Terslev, O. Hendricks, M. Østergaard, S. H. Rasmussen, M. Pfeiffer-Jensen, T. Adelsten, A. Colic, K. Danebod, M. Kildemand, A. G. Loft, H. L. Munk, J. K. Pedersen, R. Østgård, C. M. Sørensen, N. Steen Krogh, J. Nørgaard Agerbo, C. Ziegler, M. L. Hetland
Publikováno v:
Annals of the Rheumatic Diseases. 81:944.2-945
BackgroundPatients with inflammatory rheumatic diseases (IRD) have used self-isolation and social distancing during the pandemic to avoid SARS-CoV-19 infection (reference). In countries with unlimited and free access to SARS-CoV-19 testing, anxiety o
Autor:
D V Jensen, Robin Christensen, Inge Juul Sørensen, Merete Lund Hetland, A. E. Secher, P L Pedersen, Bente Glintborg, Marie Skougaard, Henrik Gudbergsen, Niels Steen Krogh
Publikováno v:
Secher, A E, Glintborg, B, Gudbergsen, H, Krogh, N S, Sørensen, I J, Jensen, D V, Christensen, R, Skougaard, M, Pedersen, P L & Hetland, M L 2019, ' Comparing patient-reported outcomes entered at home versus at hospital, and testing touch screens for initial recruitment to scientific trials in arthritis patients ', Scandinavian Journal of Rheumatology, vol. 48, no. 3, pp. 178-184 . https://doi.org/10.1080/03009742.2018.1522666
Objectives: Touch screens for entering patient-reported outcomes (PROs) are available at all Danish departments of rheumatology reporting to the nationwide DANBIO registry. This project comprises two substudies in patients with rheumatoid arthritis (
Autor:
Bente Glintborg, Anne Gitte Loft, Salome Kristensen, Inge Juul Sørensen, Frank Mehnert, Natalia Manilo, Johnny Lillelund Raun, Dorte Dalsgaard Pedersen, Jakob Espesen, Stavros Chrysidis, Hanne Merete Lindegaard, Lis Smedegaard Andersen, Oliver Hendricks, Merete Lund Hetland, Asta Linauskas, Niels Steen Krogh, Henrik Nordin, Inger Marie Jensen Hansen, D V Jensen, Susanne Højmark Jakobsen, Jolanta Grydehøj, Emina Omerovic, Kamilla Danebod, Emil Barner Dalgaard
Publikováno v:
Glintborg, B, Loft, A G, Omerovic, E, Hendricks, O, Linauskas, A, Espesen, J, Danebod, K, Jensen, D V, Nordin, H, Dalgaard, E B, Chrysidis, S, Kristensen, S, Raun, J L, Lindegaard, H, Manilo, N, Jakobsen, S H, Hansen, I M J, Pedersen, D D, Sørensen, I J, Andersen, L S, Grydehøj, J, Mehnert, F, Krogh, N S & Lund Hetland, M 2020, ' Response to ''To switch or not to switch' : the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al ', Annals of the Rheumatic Diseases, vol. 79, no. 4, e37 . https://doi.org/10.1136/annrheumdis-2018-214952
Glintborg, B, Loft, A G, Omerovic, E, Hendricks, O, Linauskas, A, Espesen, J, Danebod, K, Jensen, D V, Nordin, H, Dalgaard, E B, Chrysidis, S, Kristensen, S, Raun, J L, Lindegaard, H, Manilo, N, Jakobsen, S H, Hansen, I M J, Pedersen, D D, Sørensen, I J, Andersen, L S, Grydehøj, J, Mehnert, F, Krogh, N S & Lund Hetland, M 2020, ' Response to To switch or not to switch' : The missing piece in the puzzle of biosimilar literature?' by Scherlinger et al ', Annals of the Rheumatic Diseases, vol. 79, no. 4, e37 . https://doi.org/10.1136/annrheumdis-2018-214952
Glintborg, B, Loft, A G, Omerovic, E, Hendricks, O, Linauskas, A, Espesen, J, Danebod, K, Jensen, D V, Nordin, H, Dalgaard, E B, Chrysidis, S, Kristensen, S, Raun, J L, Lindegaard, H, Manilo, N, Jakobsen, S H, Hansen, I M J, Pedersen, D D, Sørensen, I J, Andersen, L S, Grydehøj, J, Mehnert, F, Krogh, N S & Lund Hetland, M 2020, ' Response to ''To switch or not to switch' : the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al ', Annals of the Rheumatic Diseases, vol. 79, no. 4 . https://doi.org/10.1136/annrheumdis-2018-214952
Glintborg, B, Loft, A G, Omerovic, E, Hendricks, O, Linauskas, A, Espesen, J, Danebod, K, Jensen, D V, Nordin, H, Dalgaard, E B, Chrysidis, S, Kristensen, S, Raun, J L, Lindegaard, H, Manilo, N, Jakobsen, S H, Hansen, I M J, Pedersen, D D, Sørensen, I J, Andersen, L S, Grydehøj, J, Mehnert, F, Krogh, N S & Lund Hetland, M 2020, ' Response to To switch or not to switch' : The missing piece in the puzzle of biosimilar literature?' by Scherlinger et al ', Annals of the Rheumatic Diseases, vol. 79, no. 4, e37 . https://doi.org/10.1136/annrheumdis-2018-214952
Glintborg, B, Loft, A G, Omerovic, E, Hendricks, O, Linauskas, A, Espesen, J, Danebod, K, Jensen, D V, Nordin, H, Dalgaard, E B, Chrysidis, S, Kristensen, S, Raun, J L, Lindegaard, H, Manilo, N, Jakobsen, S H, Hansen, I M J, Pedersen, D D, Sørensen, I J, Andersen, L S, Grydehøj, J, Mehnert, F, Krogh, N S & Lund Hetland, M 2020, ' Response to ''To switch or not to switch' : the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al ', Annals of the Rheumatic Diseases, vol. 79, no. 4 . https://doi.org/10.1136/annrheumdis-2018-214952
Thank you for the interest1 in our recent publication, in which we explored treatment outcomes following a Danish mandatory switch from originator to biosimilar etanercept (SB4, 50 mg) in routine care.2 We showed that of the 2061 patients who were re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b933c58f95be759c886ede1d15b976a
https://vbn.aau.dk/da/publications/9eba4499-3a28-4c04-b60d-d6ab174db85c
https://vbn.aau.dk/da/publications/9eba4499-3a28-4c04-b60d-d6ab174db85c
Autor:
Christian Møller Sørensen, Lene Terslev, J. K. Pedersen, Connie Ziegler, B. Glintborg, Oliver Hendricks, J. Nørgaard Agerbo, M.L. Hetland, Heidi Lausten Munk, Malene Kildemand, S. H. Rasmussen, M. Pfeiffer Jensen, Anne Gitte Loft, N. Steen Krogh, Ada Colic, Thomas Adelsten, D. V. Jensen, Mette Østergaard, Sara Engel, René Østgård, Kamilla Danebod
Publikováno v:
Annals of the Rheumatic Diseases. 80:234-234
Background:During the COVID-19 pandemic, widespread changes in how we work have been observed. Working from home is not an option for everyone. At work it may be difficult to keep social distance, which may lead to fear and anxiety of being infected
Autor:
Kamilla Danebod, N. Steen Krogh, Mette Østergaard, Thomas Adelsten, Christian Møller Sørensen, M.L. Hetland, Sara Engel, René Østgård, Connie Ziegler, Anne Gitte Loft, Heidi Lausten Munk, Malene Kildemand, D. V. Jensen, Oliver Hendricks, J. K. Pedersen, Ada Colic, S. H. Rasmussen, M. Pfeiffer Jensen, J. Nørgaard Agerbo, B. Glintborg, Lene Terslev
Publikováno v:
Annals of the Rheumatic Diseases. 80:865-865
Background:The COVID-19 pandemic has caused lockdown, reduced access to face-to-face consultations, anxiety about taking immunosuppressive agents and self-isolation1 which potentially impact rheumatic disease control negatively. However, changes in b
Autor:
Kamilla Danebod, Niels Lomborg, T. Thorgrimsen, Oliver Hendricks, Marlene Andersen, Hanne Merete Lindegaard, R. Ahmed, G. Kollerup, D. V. Jensen, N. Steen Krogh, Jolanta Grydehøj, M. Kalisz, B. Glintborg, I. Ruge, K. Mortensen, Anne Gitte Loft, Line Uhrenholt, Johnny Lillelund Raun, M.L. Hetland, Ada Colic
Publikováno v:
Annals of the Rheumatic Diseases. 79:1001-1002
Background:Smoking is a known risk factor for rheumatoid arthritis (RA). It is largely unknown whether smoking has any impact on disease activity and treatment outcomes (e.g. achieving remission on methotrexate and time to first biological disease mo
Autor:
Johnny Lillelund Raun, Jolanta Grydehøj, D V Jensen, Inger Marie Jensen Hansen, Hanne Merete Lindegaard, Anne Gitte Loft, Emina Omerovic, Kamilla Danebod, Oliver Hendricks, Asta Linauskas, Henrik Nordin, Merete Lund Hetland, Stavros Chrysidis, Inge Juul Sørensen, Dorte Dalsgaard Pedersen, Susanne Højmark Jakobsen, Salome Kristensen, Frank Mehnert, Lis Smedegaard Andersen, Niels Steen Krogh, Emil Barner Dalgaard, B. Glintborg, Natalia Manilo, Jakob Espesen
Publikováno v:
Glintborg, B, Loft, A G, Omerovic, E, Hendricks, O, Linauskas, A, Espesen, J, Danebod, K, Jensen, D V, Nordin, H, Dalgaard, E B, Chrysidis, S, Kristensen, S, Raun, J L, Lindegaard, H, Manilo, N, Jakobsen, S H, Hansen, I M J, Dalsgaard Pedersen, D, Sørensen, I J, Andersen, L S, Grydehøj, J, Mehnert, F, Krogh, N S & Hetland, M L 2019, ' To switch or not to switch : results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry ', Annals of the Rheumatic Diseases, vol. 78, no. 2, pp. 192-200 . https://doi.org/10.1136/annrheumdis-2018-213474
Glintborg, B, Loft, A G, Omerovic, E, Hendricks, O, Linauskas, A, Espesen, J, Danebod, K, Jensen, D V, Nordin, H, Dalgaard, E B, Chrysidis, S, Kristensen, S, Raun, J L, Lindegaard, H, Manilo, N, Jakobsen, S H, Hansen, I M J, Dalsgaard Pedersen, D, Sørensen, I J, Andersen, L S, Grydehøj, J, Mehnert, F, Krogh, N S & Hetland, M L 2019, ' To switch or not to switch: Results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry ', Annals of the Rheumatic Diseases, vol. 78, pp. 192-200 . https://doi.org/10.1136/annrheumdis-2018-213474
Glintborg, B, Loft, A G, Omerovic, E, Hendricks, O, Linauskas, A, Espesen, J, Danebod, K, Jensen, D V, Nordin, H, Dalgaard, E B, Chrysidis, S, Kristensen, S, Raun, J L, Lindegaard, H, Manilo, N, Jakobsen, S H, Hansen, I M J, Dalsgaard Pedersen, D, Sørensen, I J, Andersen, L S, Grydehøj, J, Mehnert, F, Krogh, N S & Hetland, M L 2019, ' To switch or not to switch: Results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry ', Annals of the Rheumatic Diseases, vol. 78, pp. 192-200 . https://doi.org/10.1136/annrheumdis-2018-213474
ObjectivesReal-world evidence on effectiveness of switching to biosimila r etanercept is scarce. In Denmark, a nationwide guideline of mandatory switch from 50 mg originator (ETA) to biosimilar (SB4) etanercept was issued for patients with rheumatoid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c302890950b7f04e11e32e0f3a5fd9ec
https://vbn.aau.dk/da/publications/e6e32571-23f8-49ba-9a63-52682abf94c9
https://vbn.aau.dk/da/publications/e6e32571-23f8-49ba-9a63-52682abf94c9
Autor:
Kamilla Danebod, Niels Lomborg, Johnny Lillelund Raun, Niels Steen Krogh, Salome Kristensen, Stylianos Georgiadis, Anne Gitte Loft, Frank Mehnert, Oliver Hendricks, Bente Glintborg, Merete Lund Hetland, Hafsah Nabi, Heidi Lausten Munk, Mohamad Redha Hussein, Natalia Manilo, Jens Kristian Pedersen, Marlene Andersen, Maren Høgberget Kalisz, Ada Colic, Stavros Chrysidis, D V Jensen
Publikováno v:
Annals of the Rheumatic Diseases. :annrheumdis-2021
Objectives In 2018, a nationwide mandatory switch from originator to biosimilar adalimumab was conducted in Denmark. The available biosimilar was GP2017 (Hyrimoz) in Eastern regions and SB5 (Imraldi) in Western regions. We aimed to assess the compara